Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
NYR-BI03
Myocardial Ischemia
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
31-Dec-2024
NYR-BI03 Phase Ia Clinical Trial Update 2
24-Dec-2024
Nyrada Receives A$1.235M R&D Tax Incentive Rebate
23-Dec-2024
Upcoming Expiry of Unlisted Warrants
17-Dec-2024
NYR-BI03 Phase Ia Clinical Trial Update - Correction
16-Dec-2024
NYR-BI03 Phase Ia Clinical Trial Update
9-Dec-2024
Application for quotation of securities - NYR
6-Dec-2024
Securities Purchase Plan Closure
25-Nov-2024
Investor Presentation
25-Nov-2024
Nyrada Investor Conference Call Reminder
14-Nov-2024
Change of Director's Interest Notice - GM
1
2
3
4
5
6
7
8
9
Next
